SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-029218
Filing Date
2018-05-16
Accepted
2018-05-16 16:15:38
Documents
4
Period of Report
2018-05-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv494369_8k.htm 8-K 18898
2 EXHIBIT 10.1 tv494369_ex10-1.htm EX-10.1 9042
3 EXHIBIT 99.1 tv494369_ex99-1.htm EX-99.1 9124
4 GRAPHIC image_001.jpg GRAPHIC 3584
  Complete submission text file 0001144204-18-029218.txt   43438
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 18840139
SIC: 2836 Biological Products, (No Diagnostic Substances)